top of page

🌟 Lambert-Eaton myasthenic syndrome

 🎯 Pathology

  • autoimmune disorder of the neuromuscular junction (NMJ) disorder caused by the depletion of voltage-gated calcium channels (VGCC) due to the development of autoantibodies against these channels

  • the consequence is reduced release of acetylcholine from the pre-synaptic neuron

 

🧪 Normal mechanism of acetylcholine release

  • acetylcholine is synthesised and stored in vesicles at the axon terminal of the pre-synaptic motor neuron

  • the action potential travels triggers the influx of calcium ions through the pre-synaptic VGCC

  • this release of acetylcholine into the synaptic cleft

  • in Lambert-Eaton myasthenic syndrome, calcium cannot enter the neuron due to the destruction of VGCCs, limiting the secretion of acetylcholine into the synaptic cleft

💡 Risk factors

  • malignancy as a paraneoplastic syndrome

    • small cell lung cancer (most common)

    • lymphoproliferative disorders

    • prostate cancer

  • non-paraneoplastic

    • associated autoimmune disease

    • cigarette smoking

    • HLA-B8-DR3

🩺 Clinical features

  • muscle weakness

    • improves with activity (key differentiating factor from myasthenia gravis)

    • typically affects the proximal muscles of the leg —> difficulties with standing up from a seated position

  • reduced/absent deep tendon reflexes

  • ocular and bulbar muscles are spared (in contrast to myasthenia gravis)

  • autonomic dysfunction

    • dry mouth (most commonly)

    • erectile dysfunction

    • decreased sweating

🕵️‍♂️ Investigations

  • serology

    • antibodies against VGCCs

  • repetitive nerve stimulation

    • incremental response

  • imaging

    • chest CT to exclude lung malignancy

💆‍♂️ Management

  • treat the underlying malignancy

  • symptomatic management to elevate levels of acetylcholine

    • 3,4-diaminopyridine: enhances the release of acetylcholine into the synaptic cleft

    • pyridostigmine: inhibits the degradation of acetylcholine in the synaptic cleft

  • treatment for refractory cases

    • immunosuppression with prednisolone or azathioprine

    • if severe, plasma exchange or intravenous immunoglobulin (IVIG) is considered

🧲 High-yield tips

  • repetitive nerve stimulation shows classic decremental response in myasthenia gravis while an incremental response is seen in Lambert-Eaton myasthenic syndrome

  • lung mass + muscle weakness = Lambert-Eaton myasthenic  syndrome in a patient with small cell lung cancer

  • anterior mediastinal mass + clinical weakness = myasthenia gravis in a patient with thymoma

Dr Reman AlAbdulaaly
Foundation doctor
bottom of page